海泰新光(688677.SH):力爭在年內建立起覆蓋國內大部分省市的經銷渠道
格隆匯5月9日丨海泰新光(688677.SH)於2023年4月接受機構調研,就“公司全國性銷售渠道的搭建情況?”,公司表示,公司對自有的渠道的建設遵循穩步推進的原則,主要是因為推出新產品、品牌建立都需要做大量的準備,雖然公司內窺鏡的核心部件在中國及北美市場已經得到了充分肯定,但是對於中國醫療機構來説還是新品牌。現在國產替代政策對於國內內窺鏡企業是一個發展機會,但同時也出現了大量企業一擁而上的情況,原有的市場形式、產品格局和銷售格局都被打破了,而新的格局還沒有建立起來。公司是一家技術型企業,從核心部件發展到自主整機產品,公司有其優勢的一面,有很強的底層技術和生產質量控制能力;但在品牌建設和銷售渠道方面又有弱勢的一面。公司與國藥器械、中國史賽克在國內的合作模式已經成型。同時,公司今年會加大對市場推廣的投入,在全國範圍內開展經銷商、代理商等銷售渠道建設,力爭在年內建立起覆蓋國內大部分省市的經銷渠道。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.